Bromuro de ipratropium y beta dos agonistas en la crisis de asma en niños

Romero Echague, silvia; Segura Vasi, Alvaro; Rázuri Balarezo, Antero; García Aguila, Alfredo; Ugarte Taboada, Claudia; Whu Whu, Rafael; Chiarella Ortigosa, Pascual; Zegarra Rojas, Oswaldo.
Diagnóstico (Perú) ; 33(5/6): 131-9, 1994. tab, graf
Artículo en Español | LILACS | ID: lil-227799

Documentos relacionados

  1. Noninvasive ventilation use in pediatric status asthmaticus.
  2. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation.
  3. Acute severe asthma (status asthmaticus).
  4. Asthma Severity Pathway in the PICU.
  5. Standardized Protocol Is Associated With a Decrease in Continuous Albuterol Use and Length of Stay in Critical Status Asthmaticus.
  6. Elevated Serum Lactate in Children With Status Asthmaticus Receiving Albuterol.
  7. Variability Reduction-An Essential Aspect of Quality.
  8. Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.
  9. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma.
  10. Comparison of Two Assessment Tools for Hospitalized Subjects With Asthma.